Escobedo, Albert http://orcid.org/0000-0001-7295-5111
Piccirillo, Jonathan http://orcid.org/0000-0001-9131-7270
Aranda, Juan http://orcid.org/0000-0001-9385-4651
Diercks, Tammo
Mateos, Borja http://orcid.org/0000-0002-0310-4943
Garcia-Cabau, Carla http://orcid.org/0000-0003-0533-0642
Sánchez-Navarro, Macarena http://orcid.org/0000-0002-0159-2381
Topal, Busra
Biesaga, Mateusz http://orcid.org/0000-0001-6443-1270
Staby, Lasse
Kragelund, Birthe B. http://orcid.org/0000-0002-7454-1761
García, Jesús http://orcid.org/0000-0003-2961-9790
Millet, Oscar http://orcid.org/0000-0001-8748-4105
Orozco, Modesto http://orcid.org/0000-0002-8608-3278
Coles, Murray http://orcid.org/0000-0001-6716-6150
Crehuet, Ramon http://orcid.org/0000-0002-6687-382X
Salvatella, Xavier http://orcid.org/0000-0002-8371-4185
Article History
Received: 30 April 2022
Accepted: 4 November 2022
First Online: 18 November 2022
Competing interests
: M.B. and X.S. are founders of Nuage Therapeutics. M.B. is an employee of Nuage Therapeutics. X.S. is a scientific advisor of Nuage Therapeutics. The remaining authors declare no competing interests.